#36 Healthcare's AI Inflection Point: Investing in What's Next with a16z

Healthcare is being rewritten in real time. As AI moves from promise to practice and digital innovation accelerates across the industry, organizations and entrepreneurs shaping the future are creating new possibilities for how care is delivered, experienced, and scaled. In this episode of Mavericks in Healthcare, Julie Yoo, General Partner at Andreessen Horowitz (a16z), shares why she believes healthcare is at a once-in-a-generation inflection point. Julie leads early-stage healthcare investing at a16z, a venture capital firm backing entrepreneurs and companies transforming healthcare and technology. As Julie says, "It could not be a better time to start a health tech company." Drawing from her experience as both a healthcare founder and investor, Julie explores how AI is creating new opportunities across care delivery, clinical workflows, operational efficiency, and patient engagement. She discusses the health tech trends attracting investment, the challenges founders must navigate, and why today's environment presents unprecedented opportunities to build and scale innovative healthcare solutions. From venture capital and digital health to AI's growing role in healthcare transformation, this conversation offers a front-row seat to the ideas, technologies, and innovators shaping the future of the industry. Whether you're a healthcare leader, entrepreneur, investor, or innovator, this episode provides valuable insights into where healthcare is headed next.